Therefore, it is pathologically possible that a subset of cancer cells is capable of conditional (hypoxic) androgen/AR-independence, and is selected in the resistant tumor by all types of androgen/AR-blockade strategies (Supplementary Fig. 12). The gene discussed is AR; the disease is cancer.